Skip to main content
Clinical Trials/NCT01643317
NCT01643317
Completed
Not Applicable

Screening Cardiovascular Patients for Aortic Aneurysms

Catharina Ziekenhuis Eindhoven1 site in 1 country35 target enrollmentJuly 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abdominal Aortic Aneurysm
Sponsor
Catharina Ziekenhuis Eindhoven
Enrollment
35
Locations
1
Primary Endpoint
AAA prevalence
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Screening studies for Abdominal Aortic Aneurysms (AAA) in 65 to 79 years aged men, have shown a significant reduction in AAA related mortality. In addition, the cost-effectiveness of screening for AAA in men in the Netherlands has been demonstrated by using a Markov model. Screening might be even more (cost-) effective if targeted on high risk groups, such as patients with a particular cardiovascular disease with a known increased risk of having an AAA.

Project SCAN (Screening CardioVascular patients for Aortic aNeurysms) is a project focused on targeted AAA screening to proactively diagnose patients at high risk of having an aneurysm that eventually may rupture. This pilot project aims to study the value of a screening protocol in daily practice to detect AAA's in high risk patients.

Detailed Description

1. Offering PAD and CAD patients a non-invasive abdominal ultrasound after a careful process of shared-decision making 2. Recording data on aneurysm detection on all PAD and CAD patients screened: 1. General information (age, gender) 2. Medical history on CardioVascular risk factors (such as smoking history, hypertension, and other cardiovascular medical conditions - only information that is already recorded in the patient's medical history chart) 3. AAA - Yes/ No (Yes if ≥3 cm AAA) 4. If ≥3 cm aneurysm, record exact size and outcome in time (surveillance, treatment, no treatment) 5. If treated, record treatment type (EVAR or Open) and outcome

Registry
clinicaltrials.gov
Start Date
July 2012
End Date
July 2013
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Catharina Ziekenhuis Eindhoven
Responsible Party
Principal Investigator
Principal Investigator

Joep Teijink

MD, PhD, Vascular Surgeon

Catharina Ziekenhuis Eindhoven

Eligibility Criteria

Inclusion Criteria

  • male and female patients
  • peripheral arterial disease (ankle brachial index \< 0,90 and/or reduction of \> 0.15 after exercise test) or a carotid stenosis (stenosis ≥ 50%)
  • age \> 55 year

Exclusion Criteria

  • Patients unfit for endovascular or open surgery (as judged by vascular surgeon)
  • Failure to master the dutch language

Outcomes

Primary Outcomes

AAA prevalence

Time Frame: 1 year

Study Sites (1)

Loading locations...

Similar Trials